Back to Emergency Medicine
Emergency Medicinev2013Evidence-Based

Ottawa Subarachnoid Hemorrhage (SAH) Rule for Headache Evaluation

Clinical decision rule to identify alert patients with acute headache who are at risk for subarachnoid hemorrhage. This validated tool has 100% sensitivity for ruling out SAH but should not be used alone to diagnose SAH due to low specificity (15.3%). Designed to guide decision-making for CT scanning and further investigation in emergency department patients.

Clinical Input Parameters

Clinical Assessment
Awaiting Parameters
ottawa sah result
—result
Ready to Calculate

Awaiting Clinical Input

Enter the clinical input parameters on the left and click Run Clinical Assessment to evaluate this medical calculator with deterministic clinical scoring.

Open in Web App
Clinical decision support tool for licensed medical practitioners. Confirm independently before prescribing or clinical action.

When & Why to Use

The Ottawa Subarachnoid Hemorrhage (SAH) Rule for Headache Evaluation is utilized in clinical practice for risk stratification, diagnostic probability estimation, and treatment decision-making within emergency medicine.

Use this tool during initial patient intake, emergency department workup, or bedside assessment when objective clinical scoring is required to guide management or admission decisions.

Clinical Formula & Scoring Logic

Ottawa SAH Rule = Assessment of 6 criteria: Age ≥40 years + Neck pain/stiffness + Witnessed LOC + Onset with exertion + Thunderclap headache + Limited neck flexion

Clinical Pearls & Practice Notes

  • Rule has 100% sensitivity for subarachnoid hemorrhage but low specificity (15.3%)
  • Designed as a rule-out tool - negative result can safely exclude SAH
  • Any positive criterion means SAH cannot be ruled out and further investigation is needed
  • Application criteria: Alert patients ≥15 years, new severe atraumatic headache, maximum intensity within 1 hour, presenting within 14 days
  • Exclusion criteria: New neurologic deficits, prior aneurysm/SAH/brain tumor, chronic recurrent headaches
  • Validated in multiple studies with over 4,000 patients
  • Recommended workup for positive result: Non-contrast CT within 6 hours, consider LP if high suspicion
  • The rule should not be used to diagnose SAH due to low specificity
  • Original derivation study included 2,131 patients with 132 cases of SAH
  • External validation confirmed 100% sensitivity across multiple studies
  • Clinical impact: Reduces unnecessary imaging while maintaining safety

Evidence & Literature Citations

  1. Perry JJ, Stiell IG, Sivilotti ML, Bullard MJ, Emond M, Symington C, et al. Sensitivity of computed tomography performed within six hours of onset of headache for diagnosis of subarachnoid haemorrhage: prospective cohort study. BMJ. 2011;343:d4277. doi: 10.1136/bmj.d4277.
  2. Perry JJ, Stiell IG, Sivilotti ML, Bullard MJ, Lee JS, Eisenhauer M, et al. High risk clinical characteristics for subarachnoid haemorrhage in patients with acute headache: prospective cohort study. BMJ. 2010;341:c5204. doi: 10.1136/bmj.c5204.
  3. Perry JJ, Sivilotti ML, Sutherland J, Hohl CM, Émond M, Calder LA, et al. Validation of the Ottawa Subarachnoid Hemorrhage Rule in patients with acute headache. CMAJ. 2017;189(45):E1379-E1385. doi: 10.1503/cmaj.170072.

Score Interpretation Ranges

SAH Ruled Out0 – 0 pts

Subarachnoid hemorrhage ruled out

Cannot Rule Out SAH1 – 6 pts

Cannot rule out subarachnoid hemorrhage

Need Clinical Suite Access?

Run this calculator with patient history, laboratory integration, and drug interaction safety checks on the DexaMed clinician app.

Open in Web App

Clinical Decision Support (CDS) Notice & Legal Disclaimer

This medical calculator and its scoring interpretation are provided strictly for licensed healthcare professionals and medical trainees as an educational and clinical decision support instrument. It does not replace independent clinical judgment, comprehensive patient history, physical examination, or attending physician oversight. Not FDA-cleared as an autonomous diagnostic medical device. Read the full DexaMed Medical Disclaimer.